Oral manifestations serve as potential signs of ulcerative colitis: A review
- PMID: 36248861
- PMCID: PMC9559187
- DOI: 10.3389/fimmu.2022.1013900
Oral manifestations serve as potential signs of ulcerative colitis: A review
Abstract
As an immune dysregulation-related disease, although ulcerative colitis (UC) primarily affects the intestinal tract, extraintestinal manifestations of the disease are evident, particularly in the oral cavity. Herein, we have reviewed the various oral presentations, potential pathogenesis, and treatment of oral lesions related to UC. The oral manifestations of UC include specific and nonspecific manifestations, with the former including pyostomatitis vegetans and the latter encompassing recurrent aphthous ulcers, atrophic glossitis, burning mouth syndrome, angular cheilitis, dry mouth, taste change, halitosis, and periodontitis. Although the aetiology of UC has not been fully determined, the factors leading to its development include immune system dysregulation, dysbiosis, and malnutrition. The principle of treating oral lesions in UC is to relieve pain, accelerate the healing of lesions, and prevent secondary infection, and the primary procedure is to control intestinal diseases. Systemic corticosteroids are the preferred treatment options, besides, topical and systemic administration combined with dietary guidance can also be applied. Oral manifestations of UC might accompany or precede the diagnosis of UC, albeit with the absence of intestinal symptoms; therefore, oral lesions, especially pyostomatitis vegetans, recurrent aphthous ulcer and periodontitis, could be used as good mucocutaneous signs to judge the occurrence and severity of UC, thus facilitating the early diagnosis and treatment of UC and avoiding severe consequences, such as colon cancer.
Keywords: immune dysfunction; inflammatory bowel disease; oral manifestation; pyostomatitis vegetans; ulcerative colitis.
Copyright © 2022 Li, Wu, Xie, Zhang, Jiang, Wang, Luo and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Oral pathology in inflammatory bowel disease.World J Gastroenterol. 2016 Jul 7;22(25):5655-67. doi: 10.3748/wjg.v22.i25.5655. World J Gastroenterol. 2016. PMID: 27433081 Free PMC article. Review.
-
Association of oral manifestations in ulcerative colitis: A pilot study.J Oral Maxillofac Pathol. 2018 May-Aug;22(2):199-203. doi: 10.4103/jomfp.JOMFP_223_16. J Oral Maxillofac Pathol. 2018. PMID: 30158772 Free PMC article.
-
Pyostomatitis vegetans in a pediatric patient with ulcerative colitis: case report of a rare pediatric inflammatory bowel disease extraintestinal manifestation and review of the literature.Eur J Gastroenterol Hepatol. 2020 Jul;32(7):889-892. doi: 10.1097/MEG.0000000000001723. Eur J Gastroenterol Hepatol. 2020. PMID: 32282544 Review.
-
Oral manifestation in inflammatory bowel disease: a review.World J Gastroenterol. 2013 Dec 14;19(46):8571-9. doi: 10.3748/wjg.v19.i46.8571. World J Gastroenterol. 2013. PMID: 24379574 Free PMC article. Review.
-
Pyostomatitis vegetans. A reactive mucosal marker for inflammatory disease of the gut.Arch Dermatol. 1985 Jan;121(1):94-8. doi: 10.1001/archderm.121.1.94. Arch Dermatol. 1985. PMID: 3966824
Cited by
-
Oral manifestations associated with gastrointestinal diseases - A review.Bioinformation. 2025 Mar 31;21(3):383-389. doi: 10.6026/973206300210383. eCollection 2025. Bioinformation. 2025. PMID: 40599909 Free PMC article.
-
Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism.Molecules. 2024 Aug 26;29(17):4031. doi: 10.3390/molecules29174031. Molecules. 2024. PMID: 39274878 Free PMC article.
-
Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessment.Front Immunol. 2024 Aug 7;15:1426875. doi: 10.3389/fimmu.2024.1426875. eCollection 2024. Front Immunol. 2024. PMID: 39170615 Free PMC article.
-
HIV-Related Oral Mucosa Lesions: A Cross-Sectional Study on a Cohort of Italian Patients.Biomedicines. 2024 Feb 15;12(2):436. doi: 10.3390/biomedicines12020436. Biomedicines. 2024. PMID: 38398038 Free PMC article.
-
Lower fecal microbiota transplantation ameliorates ulcerative colitis by eliminating oral-derived Fusobacterium nucleatum and virulence factor.Gut Pathog. 2024 Aug 8;16(1):42. doi: 10.1186/s13099-024-00633-9. Gut Pathog. 2024. PMID: 39118149 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials